ATE244403T1 - Test zur identifikation von inhibitoren der interaktion zwischen p53 und dm2 proteinen - Google Patents

Test zur identifikation von inhibitoren der interaktion zwischen p53 und dm2 proteinen

Info

Publication number
ATE244403T1
ATE244403T1 AT96932488T AT96932488T ATE244403T1 AT E244403 T1 ATE244403 T1 AT E244403T1 AT 96932488 T AT96932488 T AT 96932488T AT 96932488 T AT96932488 T AT 96932488T AT E244403 T1 ATE244403 T1 AT E244403T1
Authority
AT
Austria
Prior art keywords
interaction
formation
dna
proteins
test
Prior art date
Application number
AT96932488T
Other languages
English (en)
Inventor
Patrick Chene
Heinz-Kurt Hochkeppel
Original Assignee
Cancer Rec Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Rec Tech Ltd filed Critical Cancer Rec Tech Ltd
Application granted granted Critical
Publication of ATE244403T1 publication Critical patent/ATE244403T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
AT96932488T 1995-09-18 1996-09-10 Test zur identifikation von inhibitoren der interaktion zwischen p53 und dm2 proteinen ATE244403T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95810576 1995-09-18
PCT/EP1996/003957 WO1997011367A1 (en) 1995-09-18 1996-09-10 ASSAY FOR IDENTIFYING INHIBITORS OF THE INTERACTION BETWEEN PROTEINS p53 AND dm2

Publications (1)

Publication Number Publication Date
ATE244403T1 true ATE244403T1 (de) 2003-07-15

Family

ID=8221793

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96932488T ATE244403T1 (de) 1995-09-18 1996-09-10 Test zur identifikation von inhibitoren der interaktion zwischen p53 und dm2 proteinen

Country Status (7)

Country Link
US (1) US6492116B1 (de)
EP (1) EP0859956B1 (de)
AT (1) ATE244403T1 (de)
AU (1) AU7127296A (de)
DE (1) DE69628936T2 (de)
WO (1) WO1997011367A1 (de)
ZA (1) ZA967826B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9608937D0 (en) * 1996-04-29 1996-07-03 Cancer Res Campaign Tech Screening methods for therapeutics and peptides used in the screen
AU8284198A (en) 1997-07-02 1999-01-25 Board Of Regents, The University Of Texas System P53 as a regulator of cell differentiation
DE19735221C1 (de) 1997-08-14 1999-05-06 Wolfgang Willi Prof Dr Deppert Beeinflussung der Bindung von p53 an Zielgene
US6020135A (en) * 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
WO1999061608A2 (en) * 1998-05-26 1999-12-02 Institute Of Molecular And Cell Biology Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation
DE602004024831D1 (de) * 2004-04-22 2010-02-04 Ortho Mcneil Pharm Inc Hdm2-inhibitorkomplexe und verwendungen davon
US20100129933A1 (en) * 2007-04-26 2010-05-27 Forschungszentrum Karlsruhe Gmbh Method for detecting the binding between mdm2 and the proteasome
EP2224961A1 (de) * 2007-11-26 2010-09-08 The Research Foundation of the State University of New York Kleinmolekülige krebsbehandlungen, die nekrose in krebszellen verursachen, aber normale zellen nicht angreifen
US12239720B2 (en) 2018-04-06 2025-03-04 Oncolyze, Inc. Compositions for use in lysis of selective cancer cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362623A (en) * 1991-06-14 1994-11-08 The John Hopkins University Sequence specific DNA binding by p53
US5411860A (en) * 1992-04-07 1995-05-02 The Johns Hopkins University Amplification of human MDM2 gene in human tumors
US5770377A (en) * 1994-07-20 1998-06-23 University Of Dundee Interruption of binding of MDM2 and P53 protein and therapeutic application thereof

Also Published As

Publication number Publication date
ZA967826B (en) 1997-03-18
DE69628936T2 (de) 2004-05-27
EP0859956B1 (de) 2003-07-02
EP0859956A1 (de) 1998-08-26
AU7127296A (en) 1997-04-09
WO1997011367A1 (en) 1997-03-27
DE69628936D1 (de) 2003-08-07
US6492116B1 (en) 2002-12-10

Similar Documents

Publication Publication Date Title
EP0770129A4 (de) Derivate von zinkfingerproteinen und methoden
AU7301898A (en) Survivin, a protein that inhibits cellular apoptosis, and its modulation
DE69633872D1 (de) Screening-verfahren zur identifizierung von neuen antibiotika
DE69942451D1 (de) Methode zum schnellen identifizieren von kleinen organischen liganden
DE60020146D1 (de) Two-hybrid-Screeningverfahren unter Verwendung des bakteriellen Transcriptionsaktivators sigma-54
ATE315101T1 (de) Nukleinsäureliganden und ihre herstellungsmethoden
ATE244403T1 (de) Test zur identifikation von inhibitoren der interaktion zwischen p53 und dm2 proteinen
WO1997012039A3 (en) Sh2-containing inositol-phosphatase
EP1609864A3 (de) Verwendung von dem neuronalen Apoptosehemstoff Protein (NAIP)
NO20006153L (no) Poly(ADP-ribose)polymerase gen
DK0877758T3 (da) Oprenset SR-p70-protein
CA2349529A1 (en) Pge synthase and methods and means for modulating its activity
FR2623811B1 (fr) Procede de preparation d'acides phosphiniques utilises pour preparer des inhibiteurs de l'enzyme de conversion de l'angiotensine, et intermediaires ainsi obtenus
WO2001079144A3 (en) Fyn kinase as a target for modulation of integrin mediated signal transduction
DE69806107D1 (de) Methoden und reagenzien zur regulierung von apoptosis
EP0856582A3 (de) Transkription-Faktoren Hemmungs-Protein und sein DNS
AP9901510A0 (en) Polypeptides comprising gax protein domains, involved in repressing transcription and or interacting with other proteins corresponding nucleic acids andtheir use.
ATE208504T1 (de) Komplex-gebundene hemmstoffe aktivierbarer stoffwechselenzyme als molekulare marker zur diagnostik und therapieüberwachung
WO2003012103A3 (fr) Acides nucleiques codant de nouvelles proteines a boite f, leurs utilisations en diagnostic et en therapie
ATE406437T1 (de) Methode zur identifikation antifungischer moleküle, welche auf die glukanosyltransferaseaktivität wirken
EP0850249A4 (de) Neues verfahren zum nachweis von cryptosporidium
ATE271608T1 (de) Inhibitorprotein der dna-gyrase.
DE59812900D1 (de) BEEINFLUSSUNG DER BINDUNG VON p53 AN ZIELGENE
ATE385573T1 (de) Verfahren zum identifizieren von liganden der rna-polymerase sigma 70 untereinheit
AU8382701A (en) Method for identifying medically valuable active substances

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0859956

Country of ref document: EP

REN Ceased due to non-payment of the annual fee